Ventus Therapeutics
Founded 2019 · 1 known investors
Ventus discovers and develops small-molecule medicines using its proprietary ReSOLVE platform, focused on structure-based drug discovery. The company has advanced lead programs in Parkinson's disease and lupus through Phase 2 clinical trials.
AI & Machine LearningBiotechDeep TechHealthtech
Founders & leadership
JL
Judith LiebermanCo-Founder, MD, PhD
Investors · 1
In the news
- Ventus Therapeutics raises funding to expedite drug discovery platformpharmaceutical-technology.com · 2022
- Ventus will Aim $140 Million at Previously Undruggable Targets - BioSpacebiospace.com · 2022
- Montreal’s Ventus Therapeutics raises $100-million to pursue ‘Holy Grail’ disease targets - The Globe and Mailtheglobeandmail.com · 2021
- Ventus Therapeutics Closes $100 Million Series B Financing - Ventus Therapeuticsventustx.com · 2021
- Ventus Therapeutics launches to drug inflammasomes, cGAS, and morecen.acs.org · 2020
- Ventus Therapeutics Raises $60M in Series A Funding - FinSMEsfinsmes.com · 2020